Cyclerion Therapeutics’ zagociguat was granted FDA orphan designation as a treatment of mitochondrial disease, according to a post to the agency’s website. Reference Link
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CYCN:
